These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16269859)

  • 1. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
    Flomenberg N; DiPersio J; Calandra G
    Acta Haematol; 2005; 114(4):198-205. PubMed ID: 16269859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.
    Flomenberg N; Devine SM; Dipersio JF; Liesveld JL; McCarty JM; Rowley SD; Vesole DH; Badel K; Calandra G
    Blood; 2005 Sep; 106(5):1867-74. PubMed ID: 15890685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
    Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
    Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
    Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
    Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer's disease mouse model.
    Shin JW; Lee JK; Lee JE; Min WK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2011 Jul; 29(7):1075-89. PubMed ID: 21608078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
    Pusic I; DiPersio JF
    Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction.
    Devine SM; Vij R; Rettig M; Todt L; McGlauchlen K; Fisher N; Devine H; Link DC; Calandra G; Bridger G; Westervelt P; Dipersio JF
    Blood; 2008 Aug; 112(4):990-8. PubMed ID: 18426988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist.
    Liles WC; Rodger E; Broxmeyer HE; Dehner C; Badel K; Calandra G; Christensen J; Wood B; Price TH; Dale DC
    Transfusion; 2005 Mar; 45(3):295-300. PubMed ID: 15752146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro.
    Martin C; Bridger GJ; Rankin SM
    Br J Haematol; 2006 Aug; 134(3):326-9. PubMed ID: 16787495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment.
    Fukuda S; Bian H; King AG; Pelus LM
    Blood; 2007 Aug; 110(3):860-9. PubMed ID: 17416737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
    Steinberg M; Silva M
    Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization of hematopoietic stem cells into the peripheral blood.
    Damon LE; Damon LE
    Expert Rev Hematol; 2009 Dec; 2(6):717-33. PubMed ID: 21082960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.
    Hess DA; Bonde J; Craft TP; Wirthlin L; Hohm S; Lahey R; Todt LM; Dipersio JF; Devine SM; Nolta JA
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):398-411. PubMed ID: 17382247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal-derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony-stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells.
    Carion A; Benboubker L; Hérault O; Roingeard F; Degenne M; Senecal D; Desbois I; Colombat P; Charbord P; Binet C; Domenech J
    Br J Haematol; 2003 Sep; 122(6):918-26. PubMed ID: 12956762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the SDF-1-CXCR4 axis in hematopoiesis and the mobilization of hematopoietic stem cells to peripheral blood].
    Gieryng A; Bogunia-Kubik K
    Postepy Hig Med Dosw (Online); 2007 Jun; 61():369-83. PubMed ID: 17572657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
    De Clercq E
    Pharmacol Ther; 2010 Dec; 128(3):509-18. PubMed ID: 20826182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
    Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
    Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.